From: Systemic varicella-zoster virus infection in two critically ill patients in an intensive care unit
 | Case 1 | Case 2 |
---|---|---|
Sex | Male | Female |
Age | 69 | 75 |
Underlying disease | MM, bone marrow transplantation and chemotherapy | CABG, AVR, Af, DM, obesity, psoriasis vulgaris |
Disease for ICU admission | Streptococcus pneumonia-induced Purpura fulminans | Severe acute pancreatitis |
Complications after ICU admission | ARDS, Renal impairment, DIC, quadruple amputation, VAP | DIC, cerebral infarction |
History of VZV vaccination | Unknown | Unknown |
History of VZV infection | Unknown | Unknown |
Recent contact with VZV | Not likely | Not apparent |
Steroid use before admission | PSL, 5Â mg/day | PSL, 4Â mg/day |
Steroid use after admission | mPSL, started with 1Â mg/kg/day then tapered to PSL 5Â mg/day | PSL, 4Â mg/day |
APACHE II score | 26 | 20 |
SOFA score | 10 | 7 |
Onset after ICU admission, days | 71 | 16 |
Onset after intubation, days | 71 | 16 |
Blood transfusion before onset | RCC, 78 units; FFP, 27 units; PC, 510 units | None |
EIA-IgM (cutoff; 0.8) | ||
one week before onset | 0.24 | 0.22 |
at the time of onset | 0.15 | 0.15 |
after onset | 0.52 (2Â weeks) | 0.47 (1Â week) |
EIA-IgG (cutoff; 2.0) | ||
one week before onset | 13.2 | 8.2 |
at the time of onset | 34.5 | 102.5 |
after onset | >128 (2Â weeks after onset) | 120.8 (1Â week after onset) |
Distribution of vesicles | Vesicles with umbilical fossa appeared diffusely and bilaterally on face, trunk, and extremities | |
Time to cluster forming | 11Â days | 7Â days |
Treatment, dose and duration | 250Â mg of acyclovir every 24Â h intravenously for 7Â days and 5Â g/day of immunoglobulin for 3Â days | 500Â mg of acyclovir every 8Â h intravenously for 7Â days and vidarabine topically |
Outcome | Survived | Died 14Â days after the onset |